Tagged Content
Tags > Medication Updates
Year: Medication:  Abilify (aripiprazole) Addyi Antipsychotics Belsomra Brintellix Cymbalta Daytrana Diazepam Effexor Farxiga Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine/Zyprexa Opioids Rexulti Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2015 FDA approves first drug treatment for sexual desire disorder The FDA has approved Addyi (flibanserin) to treat acquired, generalized hypoactive sectual desire disorder (HSDD) in premenopausal women. FDA warns of name confusion with Brintellix (vortioxetine) and Brilinta (ticagrelor) Reports of confusion between Brintellix (an antidepressant) and Brilinta (an anti-blood clotting medication) have resulted in the wrong medication being prescribed or dispensed. FDA approves Rexulti (brexpiprazole) to treat schizophrenia and as an add-on for major depressive disorder Rexulti approved to treat adults with schizophrenia and as an add-on with antidepressants for major depressive disorder.



View all tags
View RSS XML